We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

Last year saw the exposure of illegal trials and illegal promotion of the anti-cancer drug, Letrozole, as a fertility drug in India.

More than 400 women, who had been trying in vain to conceive, were enrolled without their knowledge or consent to take part in clinical trials to see if the drug induced ovulation.

In this article, Fiona Fleck reveals that the Letrozole trials are only one example of a widespread global phenomenon. Such incidences highlight the importance of independent ethics committee approval for the sale and distribution of any drug.

Link to full WHO Bulletin article

Related topics